370 related articles for article (PubMed ID: 3292322)
1. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM.
Reaven GM; Hollenbeck C; Jeng CY; Wu MS; Chen YD
Diabetes; 1988 Aug; 37(8):1020-4. PubMed ID: 3292322
[TBL] [Abstract][Full Text] [Related]
2. Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance.
Fraze E; Donner CC; Swislocki AL; Chiou YA; Chen YD; Reaven GM
J Clin Endocrinol Metab; 1985 Nov; 61(5):807-11. PubMed ID: 3900120
[TBL] [Abstract][Full Text] [Related]
3. Relationships between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin-dependent diabetic individuals.
Golay A; Swislocki AL; Chen YD; Reaven GM
Metabolism; 1987 Jul; 36(7):692-6. PubMed ID: 3298937
[TBL] [Abstract][Full Text] [Related]
4. Relationship between plasma glucose and insulin concentration, glucose production, and glucose disposal in normal subjects and patients with non-insulin-dependent diabetes.
Chen YD; Jeng CY; Hollenbeck CB; Wu MS; Reaven GM
J Clin Invest; 1988 Jul; 82(1):21-5. PubMed ID: 3292584
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a circadian rhythm of insulin sensitivity in patients with NIDDM caused by cyclic changes in hepatic glucose production.
Boden G; Chen X; Urbain JL
Diabetes; 1996 Aug; 45(8):1044-50. PubMed ID: 8690150
[TBL] [Abstract][Full Text] [Related]
6. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance.
Reaven GM; Chen YD; Hollenbeck CB; Sheu WH; Ostrega D; Polonsky KS
J Clin Endocrinol Metab; 1993 Jan; 76(1):44-8. PubMed ID: 8421101
[TBL] [Abstract][Full Text] [Related]
7. Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus.
Reaven GM; Chen YD; Golay A; Swislocki AL; Jaspan JB
J Clin Endocrinol Metab; 1987 Jan; 64(1):106-10. PubMed ID: 3536980
[TBL] [Abstract][Full Text] [Related]
8. Effect of gemfibrozil treatment in sulfonylurea-treated patients with noninsulin-dependent diabetes mellitus.
Shen DC; Fuh MM; Shieh SM; Chen YD; Reaven GM
J Clin Endocrinol Metab; 1991 Sep; 73(3):503-10. PubMed ID: 1874929
[TBL] [Abstract][Full Text] [Related]
9. Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients. Evidence for a central role of adipose tissue.
Abbasi F; Kamath V; Rizvi AA; Carantoni M; Chen YD; Reaven GM
Diabetes Care; 1997 Dec; 20(12):1863-9. PubMed ID: 9405908
[TBL] [Abstract][Full Text] [Related]
10. Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in noninsulin-dependent diabetes mellitus.
Chen YD; Golay A; Swislocki AL; Reaven GM
J Clin Endocrinol Metab; 1987 Jan; 64(1):17-21. PubMed ID: 3782431
[TBL] [Abstract][Full Text] [Related]
11. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus.
Groop LC; Saloranta C; Shank M; Bonadonna RC; Ferrannini E; DeFronzo RA
J Clin Endocrinol Metab; 1991 Jan; 72(1):96-107. PubMed ID: 1986032
[TBL] [Abstract][Full Text] [Related]
12. Effect of differences in glucose tolerance on insulin's ability to regulate carbohydrate and free fatty acid metabolism in obese individuals.
Golay A; Chen YD; Reaven GM
J Clin Endocrinol Metab; 1986 Jun; 62(6):1081-8. PubMed ID: 3517028
[TBL] [Abstract][Full Text] [Related]
13. Increased epinephrine and skeletal muscle responses to hypoglycemia in non-insulin-dependent diabetes mellitus.
Shamoon H; Friedman S; Canton C; Zacharowicz L; Hu M; Rossetti L
J Clin Invest; 1994 Jun; 93(6):2562-71. PubMed ID: 8200993
[TBL] [Abstract][Full Text] [Related]
14. Bedtime insulin for suppression of overnight free-fatty acid, blood glucose, and glucose production in NIDDM.
Taskinen MR; Sane T; Helve E; Karonen SL; Nikkilä EA; Yki-Järvinen H
Diabetes; 1989 May; 38(5):580-8. PubMed ID: 2653929
[TBL] [Abstract][Full Text] [Related]
15. Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria.
Hollenbeck CB; Johnston P; Varasteh BB; Chen YD; Reaven GM
Diabete Metab; 1991; 17(5):483-9. PubMed ID: 1752350
[TBL] [Abstract][Full Text] [Related]
16. Relationship between hepatic glucose production and fasting plasma glucose concentration in patients with NIDDM.
Jeng CY; Sheu WH; Fuh MM; Chen YD; Reaven GM
Diabetes; 1994 Dec; 43(12):1440-4. PubMed ID: 7958496
[TBL] [Abstract][Full Text] [Related]
17. Differences in postprandial lipemia between patients with normal glucose tolerance and noninsulin-dependent diabetes mellitus.
Chen YD; Swami S; Skowronski R; Coulston A; Reaven GM
J Clin Endocrinol Metab; 1993 Jan; 76(1):172-7. PubMed ID: 8421086
[TBL] [Abstract][Full Text] [Related]
18. Glucagon does not increase plasma free fatty acid and glycerol concentrations in patients with noninsulin-dependent diabetes mellitus.
Jeng CY; Sheu WH; Jaspan JB; Polonsky KS; Chen YD; Reaven GM
J Clin Endocrinol Metab; 1993 Jul; 77(1):6-10. PubMed ID: 8100832
[TBL] [Abstract][Full Text] [Related]
19. Diurnal variation of blood ketone bodies in insulin-dependent diabetes mellitus and noninsulin-dependent diabetes mellitus patients: the relationship to serum C-peptide immunoreactivity and free insulin.
Ubukata E
Ann Nutr Metab; 1990; 34(6):333-42. PubMed ID: 2076025
[TBL] [Abstract][Full Text] [Related]
20. Fasting hypertriglyceridemia in noninsulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities.
Lewis GF; O'Meara NM; Soltys PA; Blackman JD; Iverius PH; Pugh WL; Getz GS; Polonsky KS
J Clin Endocrinol Metab; 1991 Apr; 72(4):934-44. PubMed ID: 2005221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
